Recent News

• 03.11.2025 - Leerink Global Healthcare Conference
• 03.11.2025 - Leerink Global Healthcare Conference
• 03.04.2025 - TD Cowen 45th Annual Health Care Conference
• 03.04.2025 - TD Cowen 45th Annual Health Care Conference
• 03.03.2025 - APG990 Phase 1 Interim Readout Presentation
• 03.03.2025 - APG990 Phase 1 Interim Readout Presentation
• 03.03.2025 - Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2024 Financial Results
• 03.03.2025 - Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2024 Financial Results
• 03.03.2025 - Apogee Therapeutics Announces Positive Interim Phase 1 Results from the APG990 Healthy Volunteer Trial, Unlocking Potential Maintenance Dosing Every Three and Six Months for APG279 (APG777 + APG990)
• 03.03.2025 - Apogee Therapeutics Announces Positive Interim Phase 1 Results from the APG990 Healthy Volunteer Trial, Unlocking Potential Maintenance Dosing Every Three and Six Months for APG279 (APG777 + APG990)

Recent Filings

• 03.03.2025 - EX-99.1 EX-99.1
• 03.03.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.03.2025 - 8-K Current report
• 03.03.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 02.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities